Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 1, 2005, Pages 291-292

  Wilkening, Stefan ^a   Burwinkel, Barbara ^a   Grzybowska, Ewa ^c   Klaes, Rüdiger ^b   Pamula, Jolanta ^c   Pekala, Wioletta ^c   Zientek, Helena ^c   Hemminki, Kari ^a,d   Försti, Asta ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; DNA; NUCLEAR RECEPTOR COACTIVATOR 3; POLYGLUTAMINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL;

EID: 12844266004     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.291.14.1     Document Type: Article

References (6)

1. Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997;277: 965-8.
2. Rebbeck TR, Wang Y, Kantoff PW, et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 2001;61:5420-4.
3. Kadouri L, Kote-Jarai Z, Easton DF, et al. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCAl carriers. Int J Cancer 2004;108:399-403.
4. Haiman CA, Hankinson SE, Spiegelman D, et al. Polymorphic repeat in AIB1 does not alter breast cancer risk. Breast Cancer Res 2000;2: 378-85.
5. Jin Q, Hemminki K, Grzybowska E, et al. Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancers. Int J Cancer. 2004;112: 94-9.
6. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003;25: 190-202.